Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan;43(1):257.
doi: 10.1111/liv.15451. Epub 2022 Oct 17.

Response to "Hepatitis delta virus infection in the Middle East"

Affiliations
Comment

Response to "Hepatitis delta virus infection in the Middle East"

Saleh A Alqahtani et al. Liver Int. 2023 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Lazarus JV, Al-Rifai A, Sanai FM, et al. Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: a scoping review. Liver Int. 2022;1-8. doi:10.1111/liv.15338
    1. Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol and Immunol. 2021;65:352-372. doi:10.1111/1348-0421.12916
    1. Palom A, Rando-Segura A, Vico J, et al. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D. JHEP Reports. 2022;4(10):100547. doi:10.1016/j.jhepr.2022.100547
    1. Jang TY, Wei YJ, Yeh ML, et al. Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. J Formos Med Assoc. 2021;120(1 Pt 2):303-310. doi:10.1016/j.jfma.2020.10.002
    1. Lampertico P, Roulot D, Wedemeyer H. Bulevirtide with or without PEGIFNα for patients with compensated chronic hepatitis delta: from clinical trials to real life studies. J Hepatol. 2022; in press. doi:10.1016/j.jhep.2022.06.010

Substances

LinkOut - more resources